MICHELLE A FANALE to Quality of Life
This is a "connection" page, showing publications MICHELLE A FANALE has written about Quality of Life.
Connection Strength
0.096
-
Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leuk Lymphoma. 2019 11; 60(11):2705-2711.
Score: 0.060
-
The impact of classic Hodgkin lymphoma on informal caregivers: results from the CONNECT cross-sectional survey. Support Care Cancer. 2023 Nov 02; 31(12):664.
Score: 0.020
-
Cost-effectiveness of brentuximab vedotin with chemotherapy in treatment of CD30-expressing PTCL. Am J Manag Care. 2020 02 01; 26(2):e41-e49.
Score: 0.016